167 related articles for article (PubMed ID: 31009643)
1. Computer-designed active human butyrylcholinesterase double mutant with a new catalytic triad.
Grigorenko BL; Novichkova DA; Lushchekina SV; Zueva IV; Schopfer LM; Nemukhin AV; Varfolomeev SD; Lockridge O; Masson P
Chem Biol Interact; 2019 Jun; 306():138-146. PubMed ID: 31009643
[TBL] [Abstract][Full Text] [Related]
2. Understanding the non-catalytic behavior of human butyrylcholinesterase silent variants: Comparison of wild-type enzyme, catalytically active Ala328Cys mutant, and silent Ala328Asp variant.
Lushchekina S; Nemukhin A; Varfolomeev S; Masson P
Chem Biol Interact; 2016 Nov; 259(Pt B):223-232. PubMed ID: 27062896
[TBL] [Abstract][Full Text] [Related]
3. Steady-State Kinetics of Enzyme-Catalyzed Hydrolysis of Echothiophate, a P-S Bonded Organophosphorus as Monitored by Spectrofluorimetry.
Zueva IV; Lushchekina SV; Daudé D; Chabrière E; Masson P
Molecules; 2020 Mar; 25(6):. PubMed ID: 32192230
[TBL] [Abstract][Full Text] [Related]
4. Engineering Dynamic Surface Peptide Networks on Butyrylcholinesterase
Hester KP; Bhattarai K; Jiang H; Agarwal PK; Pope C
Chem Res Toxicol; 2019 Sep; 32(9):1801-1810. PubMed ID: 31411024
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine.
Yang W; Xue L; Fang L; Chen X; Zhan CG
Chem Biol Interact; 2010 Sep; 187(1-3):148-52. PubMed ID: 20060817
[TBL] [Abstract][Full Text] [Related]
6. Specificity of ethephon as a butyrylcholinesterase inhibitor and phosphorylating agent.
Haux JE; Lockridge O; Casida JE
Chem Res Toxicol; 2002 Dec; 15(12):1527-33. PubMed ID: 12482234
[TBL] [Abstract][Full Text] [Related]
7. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
[TBL] [Abstract][Full Text] [Related]
8. An Indian butyrylcholinesterase variant L307P is not structurally stable: a molecular dynamics simulation study.
David SM; Venkatesan SK; Boopathy R
Chem Biol Interact; 2013 Mar; 203(1):30-5. PubMed ID: 23123771
[TBL] [Abstract][Full Text] [Related]
9. Catalytic activities of a cocaine hydrolase engineered from human butyrylcholinesterase against (+)- and (-)-cocaine.
Xue L; Hou S; Yang W; Fang L; Zheng F; Zhan CG
Chem Biol Interact; 2013 Mar; 203(1):57-62. PubMed ID: 22917637
[TBL] [Abstract][Full Text] [Related]
10. Amino acid residues at the N- and C-termini are essential for the folding of active human butyrylcholinesterase polypeptide.
Naik RS; Pattabiraman N; Patel KA; Doctor BP; Saxena A
Chem Biol Interact; 2013 Mar; 203(1):24-9. PubMed ID: 23044488
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of butyrylcholinesterase-catalyzed hydrolysis of acetanilides.
Masson P; Froment MT; Gillon E; Nachon F; Darvesh S; Schopfer LM
Biochim Biophys Acta; 2007 Sep; 1774(9):1139-47. PubMed ID: 17690023
[TBL] [Abstract][Full Text] [Related]
12. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
[TBL] [Abstract][Full Text] [Related]
13. Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies.
Masson P; Lushchekina S; Schopfer LM; Lockridge O
Biochem J; 2013 Sep; 454(3):387-99. PubMed ID: 23782236
[TBL] [Abstract][Full Text] [Related]
14. DNA sequence of butyrylcholinesterase from the rat: expression of the protein and characterization of the properties of rat butyrylcholinesterase.
Boeck AT; Schopfer LM; Lockridge O
Biochem Pharmacol; 2002 Jun; 63(12):2101-10. PubMed ID: 12110369
[TBL] [Abstract][Full Text] [Related]
15. Why does the G117H mutation considerably improve the activity of human butyrylcholinesterase against sarin? Insights from quantum mechanical/molecular mechanical free energy calculations.
Yao Y; Liu J; Zhan CG
Biochemistry; 2012 Nov; 51(44):8980-92. PubMed ID: 23092211
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase.
Lockridge O; Blong RM; Masson P; Froment MT; Millard CB; Broomfield CA
Biochemistry; 1997 Jan; 36(4):786-95. PubMed ID: 9020776
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
Delacour H; Lushchekina S; Mabboux I; Ceppa F; Masson P; Schopfer LM; Lockridge O
Biochem Pharmacol; 2014 Dec; 92(3):476-83. PubMed ID: 25264279
[TBL] [Abstract][Full Text] [Related]
18. Substrate selectivity of high-activity mutants of human butyrylcholinesterase.
Hou S; Xue L; Yang W; Fang L; Zheng F; Zhan CG
Org Biomol Chem; 2013 Nov; 11(43):7477-85. PubMed ID: 24077614
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
Delacour H; Lushchekina S; Mabboux I; Bousquet A; Ceppa F; Schopfer LM; Lockridge O; Masson P
PLoS One; 2014; 9(7):e101552. PubMed ID: 25054547
[TBL] [Abstract][Full Text] [Related]
20. Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency.
Zheng F; Yang W; Xue L; Hou S; Liu J; Zhan CG
Biochemistry; 2010 Oct; 49(42):9113-9. PubMed ID: 20886866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
